Abbott Laboratories (ABT)

NYSE - NYSE Delayed Price. Currency in USD
39.54-0.75 (-1.86%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close40.29
Bid39.53 x 70200
Ask39.54 x 4500
Day's Range39.51 - 40.60
52wk Range36.00 - 46.38
1y Target EstN/A
Market Cap58.12B
P/E Ratio (ttm)43.26
Avg Vol (3m)9,039,020
Dividend & Yield1.04 (2.60%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Reuters4 hours ago

    St. Jude halts certain pacemaker implants over data issue

    Medical device maker St. Jude Medical Inc said on Friday it has paused implanting of one of its cardiac pacemakers due to problems with electronic data reporting. The affected device is the Nanostim leadless cardiac pacemaker (LCP). St. Jude, which is being acquired by Abbott Laboratories, said it had seven reports of lost telemetry and heart pacing output from the devices.

  • Moody's7 hours ago

    Moody's Upgrades Four, Downgrades One and Affirms Twelve Classes of BACM 2007-3

    Approximately $1.91 Billion of Structured Securities Affected. New York, October 28, 2016-- Moody's Investors Service has upgraded the ratings on four classes, downgraded the rating on one class and affirmed ...

  • PR Newswireyesterday

    A Great Place to Work, According to Science

    "Abbott is unique in that we've been adding to our reservoir of scientific knowledge for 128 years," said John Frels, Ph.D., chair of Abbott's Scientific Governing Board, which oversees the company's senior scientific career track.  "We strive to bring in the best and brightest scientists and engineers to work on some of the biggest problems in healthcare today.